Safety, tolerability, pharmacokinetics and pharmacodynamic activity of terlipressin delivered by continuous intravenous infusion in patients with cirrhosis and refractory ascites: a phase 2a open-label trial

被引：0
|
作者：
Bajaj, Jasmohan [1 ]
Yeramian, Patrick [2 ]
Gavis, Edith [1 ]
Fagan, Andrew [1 ]
Fischer, James [3 ]
Garcia-Tsao, Guadalupe [4 ]
Angeli, Paolo [5 ]
Smith, Denise [2 ]
Adams, Jonathan [2 ]
Markham, Penelope [2 ]
机构：
[1] Hunter Holmes McGuire VA Ctr, Richmond, VA USA
[2] BioVie Inc, Los Angeles, CA USA
[3] Univ Illinois, Coll Pharm, Chicago, IL USA
[4] Yale Sch Med, New Haven, CT USA
[5] Univ Padua, Med, Padua, Italy
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT139
引用
收藏
页码：S718 / S719
页数：2
相关论文
共 50 条
  • [1] SAFETY AND TOLERABILITY OF CONTINUOUS INFUSION TERLIPRESSIN (BIV201) IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND REFRACTORY ASCITES: A PHASE 2, RANDOMIZED, CONTROLLED, OPEN-LABEL STUDY
    Weinberg, Ethan M.
    Bajaj, Jasmohan S.
    Reddy, K. Rajender
    Keaveny, Andrew Paul
    Porayko, Michael K.
    Koch, David G.
    Thuluvath, Paul J.
    Simonetto, Douglas A.
    Angeli, Paolo
    Janardhan, Sujit V.
    Orman, Eric S.
    Saab, Sammy
    Zhang, Jeffrey
    Clausen, Susan
    Palumbo, Joseph
    Markham, Penelope
    HEPATOLOGY, 2024, 79 (02) : E80 - E80
  • [2] Safety and efficacy of continuous infusion terlipressin (BIV201) in patients with decompensated cirrhosis and refractory ascites: a phase 2, randomized, controlled, open-label study
    Bajaj, Jasmohan
    Weinberg, Ethan
    Reddy, K. Rajender
    Keaveny, Andrew
    Porayko, Michael
    Koch, David
    Thuluvath, Paul
    Simonetto, Douglas
    Angeli, Paolo
    Janardhan, Sujit
    Orman, Eric
    Saab, Sammy
    Zhang, Jeffrey
    Clausen, Susan
    Palumbo, Joseph
    Markham, Penelope
    JOURNAL OF HEPATOLOGY, 2023, 78 : S101 - S101
  • [3] Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Pediatric Patients with Epilepsy: An Open-label Trial
    Farkas, M.
    Kang, H.
    Fogarasi, A.
    Bozorg, A.
    James, G.
    Krauwinkel, W.
    Morita, D.
    Will, E.
    Elshoff, J-P
    ANNALS OF NEUROLOGY, 2021, 90 : S127 - S127
  • [4] Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open-label trial
    Farkas, Mark Kristof
    Kang, Harriet
    Fogarasi, Andras
    Bozorg, Ali
    James, Gareth D.
    Krauwinkel, Walter
    Morita, Diego
    Will, Edgar
    Elshoff, Jan-Peer
    EPILEPSIA, 2022, 63 (04) : 855 - 864
  • [5] Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: an open-label trial
    Farkas, Mark Kristof
    Kang, Harriet
    Fogarasi, Andras
    Bozorg, Ali
    James, Gareth
    Krauwinkel, Walter
    Morita, Diego
    Will, Edgar
    Elshoff, Jan-Peer
    EPILEPSIA, 2021, 62 : 143 - 144
  • [6] Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in neonates with seizures: Interim analysis of a phase 2/3, open-label trial
    Krauwinkel, Walter
    Will, Edgar
    Morita, Diego
    Floricel, Florin
    Elshoff, Jan-Peer
    Pressler, Ronit
    EPILEPSIA, 2021, 62 : 268 - 268
  • [7] Effect of pro-dopamine oral docarpamine on ascites: an open-label phase 2a study to assess safety and effectiveness in patients with refractory ascites due to liver cirrhosis
    Tse, Edmund
    Kontorinis, Nick
    Weltman, Martin
    Braund, Alicia
    Sawhney, Rohit
    Tunstall, Ann
    Mian, Ibrahim
    O'Beirne, James
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 87 - 87
  • [8] An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis
    van Eijk, Ruben P. A.
    Steyn, Frederik J.
    van Mantgem, Mark R. Janse
    Schmidt, Angela
    Meyjes, Myrte
    Allen, Sally
    Daygon, Dara, V
    Loeffler, Jean-Philippe
    Al-Chalabi, Ammar
    van den Berg, Leonard H.
    Henderson, Robert D.
    Ngo, Shyuan T.
    BRAIN COMMUNICATIONS, 2025, 7 (01)
  • [9] An Open-Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia
    Fox, Susan H.
    Swan, Matthew
    Jinnah, Hyder A.
    Freitas, Maria E. T.
    Oliveira, Lais M.
    Al-Shorafat, Duha
    Fernandez, Hubert H.
    Kompoliti, Katie
    Comella, Cynthia
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (05): : 743 - 749
  • [10] Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial
    Farkas, Mark Kristof
    Beller, Cynthia
    Bozorg, Ali
    McClung, Carrie
    Roebling, Robert
    Yates, Tanisia
    Yuen, Nancy
    Makedonska, Iryna
    EPILEPSIA OPEN, 2023, 8 (01) : 146 - 153
12345